Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
BHIVA response to The Irish Times article 'Anti-HIV drug removes personal responsibility'

This piece has generated a considerable amount of concern in the HIV community already as its content is completely at odds with current recommendations by the World Health Organisation and NICE which recognise that HIV pre-exposure prophylaxis (PrEP) is an important component of HIV prevention. Numerous studies have shown that PrEP is a highly clinically and cost-effective safe intervention which reduces the risk of becoming infected with HIV by around 90%.

Published
14 hours ago
From
BHIVA
Switching from Atripla to generic-containing regimens can produce large cost savings

Switching from branded Atripla to regimens that include at least one generic drug formulation can achieve big cost savings without compromising virological efficacy, according to research from Brighton presented

Published
23 April 2017
By
Michael Carter
The living legacy of the Global Plan: eliminating HIV in children

The Journal of Acquired Immune Deficiency Syndromes (JAIDS) has released a special supplement on the incredible journey of the Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (Global Plan), which documents the history of the Global Plan and outlines what the future holds as efforts to end AIDS among women, children and adolescents accelerate.

Published
20 April 2017
From
UNAIDS
Defective HIV proviruses hinder immune system response and cure

HIV proviruses can outnumber functional HIV 1000 copies to one and the faulty proteins they create can complicate efforts to measure a patient's viral load, exhaust immune systems, shield functional HIV from attack by natural means or drugs, and seriously complicate the development of a cure.

Published
19 April 2017
From
Science Daily
Orphan Drug Designation for CytoDyn's PRO 140 Declined by the FDA

Cytodyn has announced that its application for Orphan Drug Designation (ODD) for PRO 140 was not granted by the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) because PRO 140 appears to have the potential to treat more than just the subset of multi-drug resistant HIV patients for which the designation was requested.

Published
18 April 2017
From
Cytodyn press release
Biomarker Opens New Door in HIV Cure Research

For the first time, investigators have found a biomarker that identifies some cells latently infected with HIV.

Published
14 April 2017
From
MedPage Today HIV/AIDS
We asked a scientist to explain CRISPR to us—and how it’s being used in HIV research

Perhaps you’ve heard about a research technology called CRISPR (pronounced “crisper”) in the news. Since the technology was first developed, it has generated headlines as thousands of researchers have adopted this technology as a way to edit the genes of plant, animal and human cells.

Published
12 April 2017
From
BETA blog
Health system navigators didn't improve ART initiation or TB treatment completion rates among people newly diagnosed with HIV in Durban

An intervention using health system navigators, phone support and text message reminders did not improve rates of people living with HIV initiating antiretroviral therapy (ART) or completing treatment

Published
10 April 2017
By
Michael Carter
Suicide accounts for 2% of deaths in people with HIV, twice the rate of the general population

Men living with HIV have an elevated rate of suicide, particularly in the first year after diagnosis, according to a fifteen-year study of almost 90,000 people diagnosed

Published
06 April 2017
By
Roger Pebody
How AIDS denialism spreads in Russia through online social networks

Three important factors for participation in AIDS denialist networks were determined: inadequate counselling, denial of the diagnosis because informants “felt good” and unwillingness to follow antiretroviral treatment. To our surprise, we found that the two most-known and hotly debated AIDS denial rhetorical strategies – that HIV science is fake and that it is a product of a global conspiracy – played almost no role in converting individuals to AIDS denialism.

Published
05 April 2017
From
The Conversation
← First12345...440Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.